v3.25.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Statement of Cash Flows [Abstract]    
Net loss $ (20,297,040) $ (2,873,624)
Adjustments to reconcile net loss to net cash used by operating activities    
Depreciation and amortization 648,025 673,190
Loss on disposal of property and equipment 19,668
Noncash lease expense 461,490 389,125
Goodwill impairment
Bad debt expense 10,572 35,213
Contract modification - related party 280,545
Share-based compensation 7,183 15,116
Income tax expense (96,750)
Shares issued to pay for services 40,000
Accrued interest on notes payable 530,404 657,355
Non-cash royalty income (71,464) (26,564)
Amortization of original issue discounts on notes payable 16,667
Loan origination costs 5,000 36,267
Loss on exercise of warrant liabilities 15,796,105
Changes in fair value of warrant liability 5,312,838
Changes in operating assets and liabilities net of effects from acquisition of subsidiaries:    
Trade receivables (1,536,888) (2,317,074)
Trade receivables - related party 66,057 (178,980)
Inventory 851,764 1,341,472
Contract assets (171,413) (240,478)
Prepaid expenses and other current assets (569,401) 482,853
Other assets 173,497 (225,853)
Accounts payable (518,330) (455,315)
Accounts payable - related party 408
Sales tax payable (69,054) 1,658
Operating lease liabilities (464,886) (388,516)
Deposits from customers (225,560) 150,274
Accrued expenses 972,123 (108,311)
Contract liabilities 670,221 919,090
Deferred revenue (266,217) (252,109)
Income taxes payable (38,617) (146,422)
Other liabilities 7,243 (184,261)
Net cash provided/(used) by operating activities 1,600,532 (2,752,236)
Cash Flows from Investing Activities    
Purchase of property and equipment (1,359,963) (355,308)
Proceeds from sale of property and equipment 13,511
Royalties on related party revenues 10,000
Investment in MasterpieceVR (100,000) (100,000)
Net cash used by investing activities (1,436,452) (455,308)
Cash Flows from Financing Activities    
Proceeds on revolving line of credit 18,925,223 19,360,672
Payments on revolving line of credit (19,182,809) (15,413,971)
Payments on debt (240,510) (2,634,545)
Payments on Paycheck Protection Program Loans (20,247) (20,242)
Proceeds on bank loans 28,331
Proceeds from notes payable 500,000
Proceeds from warrant exercises 1,050,597
Purchases of treasury stock (69,705)
Net cash provided by financing activities 1,032,254 1,250,540
Effect of currency translation (550,693) (304,022)
Net increase/(decrease) in cash, cash equivalents, and restricted cash 645,641 (2,261,026)
Cash, cash equivalents, and restricted cash at beginning of period 5,420,392 6,349,562
Total cash, cash equivalents, and restricted cash 6,066,033 4,088,536
Balance Sheet Accounts Included in Cash, Cash Equivalents, and Restricted Cash    
Cash and cash equivalents 4,538,405 2,916,120
Restricted cash 1,527,628 1,172,416
Supplemental Disclosure of Cash Flow Information:    
Cash paid during the period for interest 389,840 482,865
Cash paid during the period for income taxes, net of refunds 269,680 146,422
Supplemental Schedule of Non-Cash Investing and Financing Activities    
Shares issued to pay for services 40,000
Financing of fixed asset purchase 28,331
Noncash recognition of new leases 204,726
Series A Warrant Exercises $ 21,515,777

Source

PDF HTML
ZIP XBRL